Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 3 - You Need To See This

Peering Into Danaher's Recent Short Interest

Danaher's (NYSE:DHR) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 4.92 million shares sold short, which is 0.76% of all regular shares that are available for trading.

Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.71%. Currently, Danaher has a market capitalization of $180.36 billion.

Analyst Ratings for Danaher

Analyst Ratings for Danaher

Danaher (NYSE:DHR) has observed the following analyst ratings within the last quarter:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

This Is What Whales Are Betting On Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 11 strange trades.

Danaher Clocks Q1 Sales Jump Of 12%, COVID-19-Related Restrictions In China To Impact Q2 Sales

Danaher Corp (NYSE:DHR) logged Q1 FY22 adjusted EPS of $2.76, up 9.5% Y/Y, surpassing the estimate of $2.66. Sales increased 12% to $7.7 billion, with 12% non-GAAP core and 8.0% non-GAAP base business core revenue growth, beating the $7.54 billion estimate. Operating cash flow reached $2 billion. Non-GAAP free cash flow reached…

Danaher: Q1 Earnings Insights

Danaher (NYSE:DHR) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview For Danaher

Earnings Preview For Danaher

Danaher (NYSE:DHR) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Danaher will report an earnings per share (EPS) of $2.66.

Here's How Much $1000 Invested In Danaher 15 Years Ago Would Be Worth Today

Here's How Much $1000 Invested In Danaher 15 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.05% on an annualized basis producing an average annual return of 14.59%. Currently, Danaher has a market capitalization of $195.51 billion.

What Are Whales Doing With Danaher

What Are Whales Doing With Danaher

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 12 strange trades.

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.23% on an annualized basis producing an average annual return of 15.22%. Currently, Danaher has a market capitalization of $212.45 billion.

Looking At Danaher's Recent Whale Trades

Looking At Danaher's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Danaher (NYSE:DHR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much

Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.58% on an annualized basis.

Thermo Fisher Scientific vs. Danaher: Which Diagnostics & Research Stock is a Better Buy?

Thermo Fisher Scientific vs. Danaher: Which Diagnostics & Research Stock is a Better Buy?

Rising demand for advanced diagnostic devices for predicting the early development of diseases and getting accurate results within less time should drive the diagnostics and research industry’s growth. Given the rising investments in the industry, prominent players in this space, Thermo Fisher (TMO) and Danaher (DHR) should benefit. But which…

Get all your
news in one place.

100's of premium titles.
One news app.

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.65% on an annualized basis.

Alphabet And 4 Other Stocks Sold By Insiders

Nasdaq futures traded sharply lower this morning after Meta Platforms, Inc. (NASDAQ: FB) reported worse-than-expected Q4 EPS results and issued weak forecast.

Where Danaher Stands With Analysts

Within the last quarter, Danaher (NYSE:DHR) has observed the following analyst ratings:

Recap: Danaher Q4 Earnings

Danaher (NYSE:DHR) reported its Q4 earnings results on Thursday, January 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Danaher Q4 Results Beat Expectations, Clocks 21% Jump In Sales

Danaher Corporation (NYSE: DHR)

Danaher's Earnings Outlook

Danaher (NYSE:DHR) is set to give its latest quarterly earnings report on Thursday, 2022-01-27. Here's what investors need to know before the announcement. Analysts estimate that Danaher will likely report an Earnings Per Share (EPS) of $2.51.

1 2 3

Organisations

Advanced Micro Devices

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play